Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
18.75
+0.61 (3.36%)
At close: Nov 13, 2026, 4:00 PM EST
18.80
+0.05 (0.27%)
Pre-market: Nov 16, 2026, 7:00 AM EST

Acadia Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,2021,072957.8726.44517.24484.15
Revenue Growth
14.82%11.87%31.85%40.45%6.83%9.60%
Cost of Revenue
433.88417.8385.09393.26371.74258.56
Gross Profit
768.42653.71572.71333.18145.49225.59
Selling, General & Admin
646.09548.89488.43406.56369.09396.03
Operating Expenses
646.09548.89488.43406.56369.09396.03
Operating Income
122.33104.8184.28-73.38-223.6-170.44
Interest & Investment Income
32.831.7225.4617.236.610.59
Other Non Operating Income (Expenses)
2.092.371.82---
EBT Excluding Unusual Items
157.21138.9111.56-56.15-216.99-169.85
Gain (Loss) on Sale of Investments
---5.113.542.33
Gain (Loss) on Sale of Assets
--146.52---
Pretax Income
157.21138.9258.08-51.04-213.44-167.52
Income Tax Expense
-205.02-252.131.6210.252.530.35
Net Income
362.23391226.45-61.29-215.98-167.87
Net Income to Common
362.23391226.45-61.29-215.98-167.87
Net Income Growth
38.69%72.66%----
Shares Outstanding (Basic)
171168166164162160
Shares Outstanding (Diluted)
173170166164162160
Shares Change
2.82%2.14%1.55%1.32%0.74%2.01%
EPS (Basic)
2.122.321.37-0.37-1.34-1.05
EPS (Diluted)
2.092.301.36-0.37-1.34-1.05
EPS Growth
35.73%69.12%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
81.99105.15157.216.65-114.04-126.78
Free Cash Flow Per Share
0.470.620.940.10-0.70-0.79
Gross Margin
63.91%61.01%59.79%45.87%28.13%46.59%
Operating Margin
10.17%9.78%8.80%-10.10%-43.23%-35.20%
Profit Margin
30.13%36.49%23.64%-8.44%-41.76%-34.67%
Free Cash Flow Margin
6.82%9.81%16.41%2.29%-22.05%-26.19%
EBITDA
135.06116.57100.16-67.83-221.57-167.1
EBITDA Margin
11.23%10.88%10.46%-9.34%-42.84%-34.51%
D&A For EBITDA
12.7311.7615.885.552.033.34
EBIT
122.33104.8184.28-73.38-223.6-170.44
EBIT Margin
10.17%9.78%8.80%-10.10%-43.23%-35.20%
Effective Tax Rate
--12.25%---
Revenue as Reported
1,2021,072957.8726.44517.24484.15
Advertising Expenses
-31.921.19.45.541.8
SEC Filings: 10-K · 10-Q